Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia

Ann Intern Med. 1988 Feb;108(2):204-6. doi: 10.7326/0003-4819-108-2-204.

Abstract

Changes in lipids and lipoprotein fractions were studied 6 months after a combined heart and liver transplantation in a patient with terminal ischemic heart disease due to homozygous familial hypercholesterolemia. The double transplant was followed by striking decreases in total and low-density-lipoprotein cholesterol levels (-71% and -79%) and content of apolipoprotein B in the low-density-lipoprotein fraction (-74%). There was also an increase in high-density-lipoprotein cholesterol (+7.8%). These changes are greater than those reported with portacaval shunt or plasma exchange. Liver transplantation may be considered in selected patients with homozygous familial hypercholesterolemia.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Cholesterol / blood
  • Cholesterol, LDL / blood
  • Coronary Disease / etiology
  • Coronary Disease / surgery
  • Heart Transplantation*
  • Homozygote
  • Humans
  • Hyperlipoproteinemia Type II / blood*
  • Hyperlipoproteinemia Type II / complications
  • Hyperlipoproteinemia Type II / therapy
  • Lipids / blood*
  • Lipoproteins / blood*
  • Lipoproteins, LDL / blood
  • Liver Transplantation*
  • Male
  • Triglycerides / blood

Substances

  • Cholesterol, LDL
  • Lipids
  • Lipoproteins
  • Lipoproteins, LDL
  • Triglycerides
  • Cholesterol